Trial intelligence / Profile preview

Clarema cream versus Hirudoid gel for traumatic hematomas

2008-007829-40Phase 4Completed

Sponsor
Farmaceutici Damor
Start
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in hematoma and Subcutaneous Hemorrhage comparing Clarema arm with Hirudoid arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Mar 2009; status: completed.

02

Drugs

Claremamucopolysaccharide polysulphate
03

Conditions

hematomaSubcutaneous Hemorrhage

Beyond the preview

Go deeper on 2008-007829-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-007829-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call